BTAIBioXcel Therapeutics, Inc.

BTAI Stock Price, Valuation & Chart | BioXcel Therapeutics, Inc.

Compare

$0.110-0.03 (-20.36%)

At close · 02 Sept 2026, 07:59 pm

Sector: Healthcare Industry: Biotechnology BTAI intrinsic value BTAI calculated fair value vs price

Overview Financials Dividends Ratios

BTAI Historical price chart

BTAI Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization3.37M

PE Ratio-0.02

EPS-5.75

Trading Volume44.91M

Today's High/Low0.19/0.11

Dividend Yield0.00

52 Week High/Low4.29/0.11

Shares Outstanding30.88M

BTAI Financial Statement

BTAI Analyst ratings

BTAI Analysis & performance metrics

BTAI Company profile

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience…

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to…

BTAI Management team

Name

Position

Richard I. Steinhart MBACFO

Senior Vice President & Chief Financial Officer

Javier Rodriguez J.D.

Senior Vice President, Chief Legal Officer & Corporate Secretary

Frank D. Yocca Ph.D.

Executive Vice President & Chief Scientific Officer

Vimal D. Mehta Ph.D.CEO

Founder, Chief Executive Officer, President, & Director

Name

Position

Richard I. Steinhart MBACFO

Senior Vice President & Chief Financial Officer

Javier Rodriguez J.D.

Senior Vice President, Chief Legal Officer & Corporate Secretary

Frank D. Yocca Ph.D.

Executive Vice President & Chief Scientific Officer

Vimal D. Mehta Ph.D.CEO

Founder, Chief Executive Officer, President, & Director

Management Team

Richard I. Steinhart MBACFO

Senior Vice President & Chief Financial Officer

Javier Rodriguez J.D.

Senior Vice President, Chief Legal Officer & Corporate Secretary

Frank D. Yocca Ph.D.

Executive Vice President & Chief Scientific Officer

Vimal D. Mehta Ph.D.CEO

Founder, Chief Executive Officer, President, & Director

Management

Richard I. Steinhart MBACFO

Senior Vice President & Chief Financial Officer

Javier Rodriguez J.D.

Senior Vice President, Chief Legal Officer & Corporate Secretary

Frank D. Yocca Ph.D.

Executive Vice President & Chief Scientific Officer

Vimal D. Mehta Ph.D.CEO

Founder, Chief Executive Officer, President, & Director

Total 4 executives

BTAI Frequently asked questions

What is BioXcel Therapeutics, Inc. (BTAI) Stock Price?

Current stock price of BioXcel Therapeutics, Inc. (BTAI) stock is $0.110. The stock price is -20.36% lower in the session. The intraday range can be seen from this page. Volume of BioXcel Therapeutics, Inc. (BTAI) stock is 44.91M.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the BioXcel Therapeutics, Inc. (BTAI) stock price going up or down today?

The stock price of BioXcel Therapeutics, Inc. (BTAI) can change with earnings, company news, and overall market sentiment. BioXcel Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BioXcel Therapeutics, Inc. stock expensive at its current price?

Whether BioXcel Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BTAI on this page is -0.02. EPS on this page is -5.75. Compare those figures with peers and growth expectations before deciding if the current BioXcel Therapeutics, Inc. price is justified.

How has the stock price of BioXcel Therapeutics, Inc. (BTAI) performed historically?

Historical performance for BioXcel Therapeutics, Inc. (BTAI) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BTAI reacted to past earnings and market events.

Should I buy BioXcel Therapeutics, Inc. (BTAI) stock, at this price?

Buying BioXcel Therapeutics, Inc. (BTAI) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.